A detailed history of Quantitative Investment Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Quantitative Investment Management, LLC holds 5,642 shares of NBIX stock, worth $764,039. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,642
Holding current value
$764,039
% of portfolio
0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$114.58 - $153.15 $646,460 - $864,072
5,642 New
5,642 $650,000
Q4 2022

Feb 14, 2023

BUY
$106.72 - $127.06 $491,338 - $584,984
4,604 New
4,604 $549,000
Q4 2021

Feb 14, 2022

SELL
$79.65 - $106.22 $1.07 Million - $1.42 Million
-13,377 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$86.18 - $99.03 $1.15 Million - $1.32 Million
13,377 New
13,377 $1.28 Million
Q1 2020

May 15, 2020

SELL
$75.11 - $113.76 $3.88 Million - $5.87 Million
-51,628 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$86.8 - $118.57 $959,574 - $1.31 Million
11,055 Added 27.25%
51,628 $5.55 Million
Q3 2019

Nov 14, 2019

BUY
$83.82 - $101.5 $3.4 Million - $4.12 Million
40,573 New
40,573 $3.66 Million
Q2 2019

Aug 14, 2019

SELL
$72.24 - $91.27 $195,048 - $246,429
-2,700 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$69.31 - $91.53 $2.04 Million - $2.69 Million
-29,400 Reduced 91.59%
2,700 $237,000
Q4 2018

Feb 12, 2019

BUY
$68.32 - $124.36 $2.19 Million - $3.99 Million
32,100 New
32,100 $2.29 Million
Q3 2018

Nov 14, 2018

SELL
$98.88 - $125.85 $3.13 Million - $3.99 Million
-31,700 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$75.3 - $105.99 $2.39 Million - $3.36 Million
31,700 New
31,700 $3.11 Million
Q1 2018

May 15, 2018

SELL
$75.88 - $92.43 $3.16 Million - $3.85 Million
-41,700 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$58.53 - $77.59 $1.51 Million - $2 Million
-25,800 Reduced 38.22%
41,700 $3.24 Million
Q3 2017

Nov 13, 2017

BUY
$47.97 - $61.28 $3.24 Million - $4.14 Million
67,500
67,500 $4.14 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.